These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 232962)

  • 1. [Neurotoxicity of formyl leurosine. An experimental and clinical study (author's transl)].
    Hildebrand J; Joffroy A; Vauthier J; Flamant-Durand J
    Acta Neurol Belg; 1979; 79(4):322-34. PubMed ID: 232962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotoxicity of formyl leurosine. An experimental and clinical study (author's transl)].
    Hildebrand J; Joffroy A; Vauthier J; Flament-Durand J
    Acta Neurol Belg; 1979; 79(4):322-34. PubMed ID: 539376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive toxicity of vincristine and other drugs for the peripheral nervous system. Three case reports.
    Hildebrand J; Kenis Y
    Acta Neurol Belg; 1971; 71(6):486-91. PubMed ID: 4336078
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
    Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
    Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The early phase of vincristine-induced neuropathy. Electrophysiological evidence of a "dying-back" phenomenon (author's transl)].
    Sebille A; Parlier Y
    Nouv Presse Med; 1981 Jul; 10(29):2417-20. PubMed ID: 6265865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
    Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
    Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
    Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
    Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vincristine neurotoxicity in rodents.
    Uy QL; Moen TH; Johns RJ; Owens AH
    Johns Hopkins Med J; 1967 Nov; 121(5):349-60. PubMed ID: 4294689
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic and morphometric studies on the peripheral nerves of rats intoxicated with methylmercury compound (author's transl)].
    Kumamoto T
    Rinsho Shinkeigaku; 1980 Jan; 20(1):31-9. PubMed ID: 6245826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiological studies in vincristin-polyneuropathy (author's transl)].
    Mamoli B; Heiss WD; Podreka I; Turnheim M
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1980 Mar; 11(1):21-7. PubMed ID: 6773738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Superiority of intrafascicular neurography over conventional nerve conduction studies in evaluating axonal degeneration].
    Hasegawa O; Matsumoto S; Iino M; Kurita R; Yoshii T
    No To Shinkei; 1999 Apr; 51(4):313-6. PubMed ID: 10363265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral neuropathy due to vincristine. Ultrastructural study of muscle and peripheral nerve biopsy].
    Vallat JM; Vital C; Vallat M; Julien J; Riemens V; Le Blanc M
    Rev Neurol (Paris); 1973 Dec; 129(6):365-8. PubMed ID: 4368208
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuronal involvement in cisplatin neuropathy: prospective clinical and neurophysiological studies.
    Krarup-Hansen A; Helweg-Larsen S; Schmalbruch H; Rørth M; Krarup C
    Brain; 2007 Apr; 130(Pt 4):1076-88. PubMed ID: 17301082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the effects of isaxonine on retrograde axon degeneration induced by vincristine in man (author's transl)].
    Guiheneuc P; Ginet J; Grolleau JY; Rojouan J
    Nouv Presse Med; 1982 Apr; 11(16):1257-61. PubMed ID: 6896575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Arceo R; Brosnan C; Arezzo J; Schaumburg H
    Lab Invest; 1992 Jan; 66(1):63-74. PubMed ID: 1309930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
    Schilder RJ; LaCreta FP; Perez RP; Johnson SW; Brennan JM; Rogatko A; Nash S; McAleer C; Hamilton TC; Roby D
    Cancer Res; 1994 Feb; 54(3):709-17. PubMed ID: 8306332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with vincristine--associated neurotoxicity.
    Othieno-Abinya NA; Nyabola LO
    East Afr Med J; 2001 Jul; 78(7):376-8. PubMed ID: 11957264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.